Primary Sjögren syndrome: an update on current pharmacotherapy options and future directions

Complete Remission of Protein-Losing Gastroenteropathy Associated With Sjögren's Syndrome by B Cell-Targeted Therapy With Rituximab

(2012) Yoshika Uraoka et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

B-cell-depleting Therapy in Systemic Lupus Erythematosus

(2012) Manuel Ramos-Casals et al.   AMERICAN JOURNAL OF MEDICINE

Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab

(2012) P M Meiners et al.   ANNALS OF THE RHEUMATIC DISEASES

B-Lymphocytes Govern the Pathogenesis of Sjogren's Syndrome

(2012) Pierre Youinou et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Interleukin-1 receptor mediates the interplay between CD4+ T cells and ocular resident cells to promote keratinizing squamous metaplasia in Sjögren's syndrome

(2012) Ying-Ting Chen et al.   LABORATORY INVESTIGATION

Trial of SLE therapies in real-world settings

(2012) Manuel Ramos-Casals et al.   Nature Reviews Rheumatology

Topical and systemic medications for the treatment of primary Sjögren's syndrome

(2012) Manuel Ramos-Casals et al.   Nature Reviews Rheumatology

Interleukin-1 Inhibition and Fatigue in Primary Sjögren's Syndrome – A Double Blind, Randomised Clinical Trial

(2012) Katrine Brække Norheim et al.   PLoS One

Primary Sjogren syndrome

(2012) M. Ramos-Casals et al.   BMJ-British Medical Journal

EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome

(2011) R. Seror et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy of rituximab in primary Sjögren's syndrome with peripheral nervous system involvement: results from the AIR registry

(2011) A Mekinian et al.   ANNALS OF THE RHEUMATIC DISEASES

Computed tomography scanning facilitates the diagnosis of sacroiliitis in patients with suspected spondylarthritis: Results of a prospective multicenter French cohort study

(2011) Valérie Devauchelle-Pensec et al.   ARTHRITIS AND RHEUMATISM

Dramatic Reversal of Lymphocytic Interstitial Pneumonitis in Sjögren’s Syndrome With Rituximab

(2011) Morris A. Swartz et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Treatment of Mucosa-associated Lymphoid Tissue Lymphoma in Sjögren’s Syndrome: A Retrospective Clinical Study

(2011) RODNEY P.E. POLLARD et al.   JOURNAL OF RHEUMATOLOGY

Prognosis and Outcome of Non-Hodgkin Lymphoma in Primary Sjögren Syndrome

(2011) Michael Voulgarelis et al.   MEDICINE

The role of antimalarial agents in the treatment of SLE and lupus nephritis

(2011) Senq-J Lee et al.   Nature Reviews Nephrology

Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases

(2011) P. Engel et al.   PHARMACOLOGICAL REVIEWS

Fatigue and depression predict physician visits and work disability in women with primary Sjogren's syndrome: results from a cohort study

(2011) G. Westhoff et al.   RHEUMATOLOGY

Interstitial cystitis: a rare manifestation of primary Sjögren’s syndrome, successfully treated with low dose cyclosporine

(2011) Hakan Emmungil et al.   RHEUMATOLOGY INTERNATIONAL

Primary Sjögren’s syndrome in Moroccan patients: characteristics, fatigue and quality of life

(2011) Yousra Ibn Yacoub et al.   RHEUMATOLOGY INTERNATIONAL

Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sjögren's syndrome: A national multicentric retrospective study

(2011) Stéphanie Rist et al.   ARTHRITIS CARE & RESEARCH

Interleukin-1 as a Phenotypic Immunomodulator in Keratinizing Squamous Metaplasia of the Ocular Surface in Sjögren's Syndrome

(2010) Ying-Ting Chen et al.   AMERICAN JOURNAL OF PATHOLOGY

Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled trial

(2010) J. M. Meijer et al.   ARTHRITIS AND RHEUMATISM

Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study

(2010) C. N. Pisoni et al.   ARTHRITIS AND RHEUMATISM

Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial

(2010) Deborah M. Friedman et al.   ARTHRITIS AND RHEUMATISM

Pathogenesis of Sjögrenʼs syndrome and therapeutic consequences

(2010) Xavier Mariette et al.   CURRENT OPINION IN RHEUMATOLOGY

Treatment of Primary Sjögren Syndrome

(2010) Manuel Ramos-Casals et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The IgG molecule as a biological immune response modifier: Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders

(2010) Mark Ballow   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

B cells as therapeutic targets in SLE

(2010) Iñaki Sanz et al.   Nature Reviews Rheumatology

The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus

(2009) Michael P. Cancro et al.   JOURNAL OF CLINICAL INVESTIGATION

Successful treatment of relapsing autoimmune pancreatitis in primary Sjögren’s syndrome with Rituximab: report of a case and review of the literature

(2009) Juan C. Rueda et al.   RHEUMATOLOGY INTERNATIONAL

Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study

(2008) S Dass et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

(2008) G Ruiz-Irastorza et al.   ANNALS OF THE RHEUMATIC DISEASES

Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjögren’s syndrome

(2008) D Sánchez-Cano et al.   LUPUS